CV Sciences, Inc. announced that it has received $1.59 million in funding from Streeterville Capital, LLC
August 18, 2022
Share
CV Sciences, Inc. announced a private placement through the issue and sold Secured Promissory Note in the original principal amount of $2,000,000. The Note carries an original issuance discount of $400,000 and the company agreed to pay $10,000 to cover legal fees, each of which were deducted from the proceeds of the note received by the company which resulted in a purchase price received by the company of $1,590,000.
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). It also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands, such as +PlusCBD and Cultured Foods in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its +PlusCBD branded products are sold at select retail locations throughout the United States. The Company's Cultured Foods brand provides a variety of 100% plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience.
CV SCIENCES, INC. 
